PSYENCE BIOMEDICAL Stock Price, News & Analysis
Company Description
PSYENCE BIOMEDICAL (NASDAQ: PBMWW) is a publicly traded company.
PBMWW stock has gained 7.1% over the past year. Shares last traded at $0.0182.
On a trailing twelve-month basis, PSYENCE BIOMEDICAL reported net income of $1.0M.
This page provides a comprehensive overview of PBMWW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PSYENCE BIOMEDICAL (PBMWW) stock last traded at $0.0182. Over the past 12 months, the stock has gained 7.1%.
Latest News
SEC Filings
PSYENCE BIOMEDICAL has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on March 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PBMWW SEC filings →
Financial Highlights
net income was $1.0M. The company generated -$3.7M in operating cash flow.
Upcoming Events
Short Interest History
Short interest in PSYENCE BIOMEDICAL (PBMWW) currently stands at 17.5 thousand shares, down 26.0% from the previous reporting period, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for PSYENCE BIOMEDICAL (PBMWW) currently stands at 1.1 days, down 6.8% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.8 days.